76 results
8-K
EX-10.2
LSTA
Lisata Therapeutics Inc
15 Sep 22
Caladrius Biosciences and Cend Therapeutics Announce Closing of Merger and the Emergence of Lisata Therapeutics
9:16am
or records given or reports made to the Company by an independent certified public accountant or by an appraiser or other expert selected
424B3
LSTA
Lisata Therapeutics Inc
29 Jul 22
Prospectus supplement
4:06pm
is not a legal, regulatory, tax or accounting expert and relied on the assessments made by Caladrius and its advisors with respect to such issues. Back Bay … experience.
Michael H. Davidson, M.D. Dr. Davidson joined the Caladrius Board of Directors in July 2020. He is an industry leader and expert
425
f8cs e4xcs3p
27 Apr 22
Business combination disclosure
5:26pm
8-K
hrq5v82archy1
28 Jul 20
Caladrius Biosciences Appoints Dr. Michael H. Davidson
8:24am
8-K
EX-99.1
8omg inq5bdc9pmc0b
28 Jul 20
Caladrius Biosciences Appoints Dr. Michael H. Davidson
8:24am
424B5
juiyljqagc ohah74z
14 Mar 19
Prospectus supplement for primary offering
4:23pm
424B5
dl5eb2b cvb
3 Jun 14
Prospectus supplement for primary offering
12:00am
8-K
a8ppktt
14 Apr 14
Entry into a Material Definitive Agreement
12:00am